Clinical Trials Directory

Trials / Unknown

UnknownNCT01114789

Impact on the Proteolysis of Obesity in Dialysis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to determine whether obesity has a protective effect on muscle proteolysis in hemodialysis patients submitted to a short starvation. This effect will be tested by comparing measuring muscle proteolysis, using regional infusion of a tracer amino acid (D5 phenylalanine) in two groups of obese and non-obese patients compared to obese and non-obese control subjects.

Detailed description

In hemodialysis patients, the risk of death decreases almost linearly as BMI increases, including in obese patients. Experimental data suggest that obesity may be associated with a reduction of muscle proteolysis during fasting. In the hemodialysis patients, after an overnight fast an increased use of endogenous energy stores has been reported. The objective of the study is to evaluate the potentially "protective" effect of obesity on protein catabolism during short fasting periods. Twenty non diabetic patients (men and women) on maintenance hemodialysis for more than six months, aged of 30 to 70 years, will be included: 10 obese (BMI ≥ 30) and 10 non obese patients (18.5 \<BMI \<25) will be compared with 20 healthy volunteers (men and women) aged 30 to 70 years, obese and non obese, according to the same criteria. On the investigation day, tracer kinetic studies will be associated with resting energy expenditure measurements and body composition analysis (using dual energy x-ray absorptiometry (DXA).

Conditions

Interventions

TypeNameDescription
OTHERProteolysisprotocol designed to examine the effect of obesity on muscle proteolysis in hemodialysis and control

Timeline

Start date
2011-01-01
Primary completion
2012-12-01
Completion
2013-03-01
First posted
2010-05-03
Last updated
2011-01-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01114789. Inclusion in this directory is not an endorsement.